# Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.

> **NCT02089841** · PHASE4 · COMPLETED · sponsor: **Richard Mwaiswelo** · enrollment: 140 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** Artemether-lumefantrine

## Key facts

- **NCT ID:** NCT02089841
- **Lead sponsor:** Richard Mwaiswelo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2014-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02089841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02089841, "Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02089841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*